Trials / Terminated
TerminatedNCT02093494
Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device When Collected Through Peripheral Intravenous Catheters
A Randomized, Open Label Study to Evaluate the Effectiveness of the MMT Initial Specimen Diversion Device in Reducing Blood Culture Contamination Compared to Laboratory Standard Procedures When Collected Through Peripheral Intravenous Catheters (PIVC)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Magnolia Medical Technologies, Inc. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, open label study to evaluate the Initial Specimen Diversion Device (ISDD) in reducing the contamination rate in blood culture analysis. Blood culture data will be derived from inpatient and/or outpatient settings in a variety of hospital departments (e.g. ER, surgical, medical, etc.). Only samples that are collected via PIVC's may be included in this study. The ISDD will be compared to current laboratory practices for the collection of blood for culture purposes. Laboratory Standard Procedures (LSP) is defined as collection of venipuncture blood for culture without an initial diversion method to divert and sequester potential blood contaminants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Initial Specimen Diversion Device (ISDD) | |
| PROCEDURE | Lab standard practice (LSP) | |
| DEVICE | Peripheral Intravenous Catheters (PIVC) |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2015-05-01
- Completion
- 2015-05-01
- First posted
- 2014-03-21
- Last updated
- 2017-08-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02093494. Inclusion in this directory is not an endorsement.